Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07151859Not ApplicableRecruiting

Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration

Role: lead

NCT06809543Not ApplicableRecruiting

Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy

Role: lead

NCT07185191Not ApplicableNot Yet Recruiting

Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS)

Role: lead

NCT05936437Not ApplicableCompleted

Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment

Role: lead

NCT05322005Not ApplicableCompleted

Study of Clinical Performance and Safety of Treatments in Degenerative Meniscopathy With Injection of Polynucleotides

Role: lead

NCT06821854Not ApplicableCompleted

Efficacy and Safety of PN20 (Plinest) for the Improvement of Skin Hydration

Role: lead

NCT06821867Not ApplicableCompleted

Efficacy and Safety of PN+HA (NEWEST) for the Improvement of Skin Hydration

Role: lead

NCT03388255Phase 4Terminated

Efficacy and Safety of PLACENTEX ® i.m. in Patients With Scleroderma Diseases

Role: lead

All 8 trials loaded